Ivabradine for Rate Control in Permanent Atrial Fibrillation

Summary

Ivabradine may be useful as a rate controlling agent in atrial fibrillation without negative effects on hemodynamics and inotropy. The objective in this proof of concept study is to investigate the hypothesis that ivabradine will slow the ventricular response in patients with permanent atrial fibrillation and previously-implanted pacemakers.

Timeline

Start

2019-06-15

Primary completion

2019-09-17

Completion

2019-09-17

Drugs

Indications